<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>G.S. Mountzios | Prof. Nikolaos Korfiatis</title><link>https://nkorf.github.io/authors/g.s.-mountzios/</link><atom:link href="https://nkorf.github.io/authors/g.s.-mountzios/index.xml" rel="self" type="application/rss+xml"/><description>G.S. Mountzios</description><generator>HugoBlox Kit (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Thu, 01 Jan 2026 00:00:00 +0000</lastBuildDate><item><title>Association patterns among patient-reported adverse events in advanced NSCLC: A post-hoc analysis of the CLIMEDIN randomized controlled trial</title><link>https://nkorf.github.io/publications/kosmidis2026jco/</link><pubDate>Thu, 01 Jan 2026 00:00:00 +0000</pubDate><guid>https://nkorf.github.io/publications/kosmidis2026jco/</guid><description/></item><item><title>Comprehensive Molecular Profiling of Advanced NSCLC in Greek Patients: A Prospective HeCOG Study</title><link>https://nkorf.github.io/publications/kosmidis2026ctrc/</link><pubDate>Thu, 01 Jan 2026 00:00:00 +0000</pubDate><guid>https://nkorf.github.io/publications/kosmidis2026ctrc/</guid><description/></item><item><title>SNF-CLIMEDIN: A Randomized Trial of Digital Support and Intervention in Patients With Advanced Non–Small Cell Lung Cancer. A Hellenic Cooperative Oncology Group Study</title><link>https://nkorf.github.io/publications/kosmidis2026jcocci/</link><pubDate>Thu, 01 Jan 2026 00:00:00 +0000</pubDate><guid>https://nkorf.github.io/publications/kosmidis2026jcocci/</guid><description/></item><item><title>Frequency of Adverse Events Reported Digitally by Patients with Advanced NSCLC: Analysis From CLIMEDIN, a HeCOG Study</title><link>https://nkorf.github.io/publications/kosmidis2025jto/</link><pubDate>Wed, 01 Jan 2025 00:00:00 +0000</pubDate><guid>https://nkorf.github.io/publications/kosmidis2025jto/</guid><description/></item><item><title>SNF-CLIMEDIN: A HECOG prospective randomized trial of digital support and intervention in patients with advanced NSCLC—Final results</title><link>https://nkorf.github.io/publications/kosmidis2025jco/</link><pubDate>Wed, 01 Jan 2025 00:00:00 +0000</pubDate><guid>https://nkorf.github.io/publications/kosmidis2025jco/</guid><description/></item><item><title>Analysis of evolution of patient reported side effects during treatment for advanced NSCLC</title><link>https://nkorf.github.io/publications/linardou2024aoo/</link><pubDate>Mon, 01 Jan 2024 00:00:00 +0000</pubDate><guid>https://nkorf.github.io/publications/linardou2024aoo/</guid><description/></item><item><title>SNF-CLIMEDIN: A prospective randomized trial of digital intervention in patients with advanced NSCLC—A HeCOG study</title><link>https://nkorf.github.io/publications/kosmidis2024jco/</link><pubDate>Mon, 01 Jan 2024 00:00:00 +0000</pubDate><guid>https://nkorf.github.io/publications/kosmidis2024jco/</guid><description/></item><item><title>Clinical and molecular study with digital support of advanced non-small cell lung cancer patients: SNF-CLIMEDIN, a prospective randomized Hellenic Cooperative Oncology Group study</title><link>https://nkorf.github.io/publications/linardou2023aoo/</link><pubDate>Sun, 01 Jan 2023 00:00:00 +0000</pubDate><guid>https://nkorf.github.io/publications/linardou2023aoo/</guid><description/></item></channel></rss>